Neurologic complications of lymphoma and leukemia.
 |
Related Articles |
Neurologic complications of lymphoma and leukemia.
Semin Oncol. 2006 Jun;33(3):342-7
Authors: Glass J
Lymphoma and leukemia are systemic diseases that affect many end-organs, including the central nervous system. These cancers may directly affect the central or peripheral nervous systems by the production of intraparenchymal or extra-axial mass lesions or by meningeal infiltration. Vascular occlusion may occur as a result of blockage of blood vessels by tumor cells. A variety of paraneoplastic syndromes occur and are most commonly associated with plasma cell tumors. Coagulopathy and metabolic disturbances are direct and indirect effects of these cancers and also are associated with their treatment, resulting in disturbances of consciousness, intracranial hemorrhage, or ischemic stroke. The agents used in the treatment of lymphoma and leukemia are also associated with neurological toxicity. This chapter reviews these neurological manifestations of lymphoma and leukemia and their therapies.
PMID: 16769423 [PubMed - in process]
Related posts:
- Induction of apoptosis by xanthones from mangosteen in human leukemia cell lines.
- Anti-HIV agent MAP30 modulates the expression profile of viral and cellular genes for proliferation and apoptosis in AIDS-related lymphoma cells infected with Kaposi’s sarcoma-associated virus.
- 1-(3,4-dimethoxyphenyl)-3,5-dodecenedione (I6) induces G1 arrest and apoptosis in human promyelocytic leukemia HL-60 cells.
- An association between manganese superoxide dismutase polymorphism and outcome of chemotherapy in acute myeloid leukemia.
- Preferential target is mitochondria in alpha-mangostin-induced apoptosis in human leukemia HL60 cells.